Literature DB >> 3882564

Survey of immunoglobulin A protease activity among selected species of Ureaplasma and Mycoplasma: specificity for host immunoglobulin A.

K Kapatais-Zoumbos, D K Chandler, M F Barile.   

Abstract

Because immunoglobulin A (IgA) is the predominant immunoglobulin at mucosal surfaces, IgA proteases produced by pathogenic bacteria are considered potential virulence factors for organisms that cause disease or gain entry at mucous membranes. To determine the role of IgA protease in the pathogenicity of mycoplasmal disease, a variety of human and animal mycoplasma and ureaplasma species were examined for IgA protease activity with human, murine, porcine, and canine IgA. None of the mycoplasma species examined showed detectable IgA protease activity with any of the IgAs tested. Twenty-eight strains of Ureaplasma urealyticum isolated from human urogenital tissues cleaved human IgA1, but no cleavage of human IgA2 or murine, porcine, or canine IgA was observed. Ureaplasmas isolated from nonhuman hosts (feline, canine, avian, and bovine [Ureaplasma diversum]) did not cleave human IgA1. Two strains of canine ureaplasmas were able to cleave canine IgA, but not murine IgA. Thus, ureaplasmas from other species can produce IgA protease, but the specificity of the enzyme was restricted to the IgA of the appropriate host. This finding suggests that IgA proteases could play a role in the selective host specificity of mucosal pathogens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882564      PMCID: PMC261363          DOI: 10.1128/iai.47.3.704-709.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers.

Authors:  H Brunner; H B Greenberg; W D James; R L Horswood; R B Couch; R M Chanock
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

Review 2.  The role of the secretory immune system in protection against agents which infect the respiratory tract.

Authors:  R H Waldman; R Ganguly
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

3.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

4.  Ciliostatic, hemagglutinating, and proteolytic activities in a cell extract of Mycoplasma pneumoniae.

Authors:  D K Chandler; M F Barile
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

Review 5.  Secretory immunity and the bacterial IgA proteases.

Authors:  S J Kornfeld; A G Plaut
Journal:  Rev Infect Dis       Date:  1981 May-Jun

6.  Serological analysis of ureaplasmas isolated from various animals.

Authors:  K Koshimizu; H Kotani; K Yamamoto; T Magaribuchi; R Harasawa; M Ito; M Ogata
Journal:  Isr J Med Sci       Date:  1984-10

7.  A newly discovered mycoplasma in the human urogenital tract.

Authors:  J G Tully; D Taylor-Robinson; R M Cole; D L Rose
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

8.  Loss of antibody activity in human immunoglobulin A exposed extracellular immunoglobulin A proteases of Neisseria gonorrhoeae and Streptococcus sanguis.

Authors:  A G Plaut; J V Gilbert; R Wistar
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

9.  Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease.

Authors:  M Kilian; J Mestecky; R E Schrohenloher
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

10.  Immunoglobulin A1 protease production by Haemophilus influenzae and Streptococcus pneumoniae.

Authors:  C J Male
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

View more
  8 in total

1.  Characterization of the immunoglobulin A protease of Ureaplasma urealyticum.

Authors:  R K Spooner; W C Russell; D Thirkell
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 2.  Procession to pediatric bacteremia and sepsis: covert operations and failures in diplomacy.

Authors:  Stacey L Bateman; Patrick C Seed
Journal:  Pediatrics       Date:  2010-06-21       Impact factor: 7.124

Review 3.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 4.  Mycoplasma, Ureaplasma, and adverse pregnancy outcomes: a fresh look.

Authors:  Bryan Larsen; Joseph Hwang
Journal:  Infect Dis Obstet Gynecol       Date:  2010-07-12

Review 5.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553

6.  Pathogenesis to treatment: preventing preterm birth mediated by infection.

Authors:  J A McGregor; J I French
Journal:  Infect Dis Obstet Gynecol       Date:  1997

7.  Mycoplasma pneumoniae downregulates RECK to promote matrix metalloproteinase-9 secretion by bronchial epithelial cells.

Authors:  Lianmei Qin; Lu Liu; Yueping Wu; Yiwen Chen; Yueyue Wu; Haodang Luo; Yixuan Xi; Feichen Xiu; Jun Hu; Liesong Chen; Ning Wu; Jun He; Yanhua Zeng; Cuiming Zhu; Xiaoxing You
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

Review 8.  Subversion of the Immune Response by Human Pathogenic Mycoplasmas.

Authors:  Lianmei Qin; Yiwen Chen; Xiaoxing You
Journal:  Front Microbiol       Date:  2019-08-21       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.